Monument Health Opens Region's First Epilepsy Monitoring Unit in Rapid City

Monument Health has opened the first Epilepsy Monitoring Unit (EMU) in its region at its Rapid City, South Dakota facility, ending a pattern in which patients suspected of seizure disorders had to travel to major academic centers for the long-term scalp video-EEG evaluation that definitive diagnosis requires.

The unit's opening addresses a concrete gap in neurodiagnostic access across western South Dakota and the surrounding area. Until now, the region had no dedicated EMU — a specialized inpatient setting where patients undergo continuous scalp electroencephalography paired with synchronized video recording over days, with antiseizure medication tapered under supervision to provoke and capture habitual events. That admission type is the diagnostic backbone of epilepsy care: it allows epileptologists to classify events as epileptic or non-epileptic, localize seizure onset, and distinguish focal from generalized epilepsy before committing patients to long-term pharmacotherapy or referring them for surgical evaluation.

For clinical neurophysiology readers, the significance is logistical as much as clinical. Prolonged video-EEG monitoring demands dedicated beds, hardwired or wireless EEG amplifiers running around the clock, trained EEG technologists to maintain electrode integrity across multi-day admissions, and 24-hour event review capability. Building that infrastructure outside a metropolitan academic center is a recognized barrier; the absence of an EMU typically means patients face referral delays of months, long-distance travel, and, for events that are psychogenic or physiologic mimics, years of unnecessary antiseizure medication. A local unit compresses that pathway.

The monitoring model an EMU institutionalizes matters for a large share of the epilepsy population. Differential diagnosis of paroxysmal events is unreliable on history alone, and medication selection depends on getting the classification right the first time. For patients whose seizures prove drug-resistant, the inpatient recordings also establish whether they are candidates for phase-one presurgical workup — intracranial monitoring, and ultimately resective or neuromodulatory treatment. Each of those downstream steps begins with the kind of scalp video-EEG capture the new unit now provides close to home.

Monument Health's investment also carries implications for the regional EEG workforce. EMUs concentrate demand for registered EEG technologists, electroencephalographers available for daily reads, and epilepsy-trained nursing staff who can recognize ictal semiology in real time and respond during medication withdrawal. Health systems that open monitoring units typically build those roles locally rather than relying on teleradiology-style remote interpretation alone, since ictal review is time-critical.

Patients and families in the Rapid City area previously shouldered the travel burden — often to Denver, Rochester, or Omaha — for what is fundamentally a routine, if resource-intensive, inpatient diagnostic stay. Keeping those admissions local reduces cost, keeps patients near their referring neurologists, and creates a referral node for the broader Black Hills region, including rural and Native American communities whose distance from tertiary centers has historically compounded diagnostic delay.

The announcement positions Monument Health as the first mover in a market that had no competing EMU offering. As the unit ramps up, the practical benchmarks to watch will be admission volume, time from referral to monitoring, and whether drug-resistant cases identified locally flow efficiently into surgical evaluation pathways at partner epilepsy centers — the measures that determine whether geographic access translates into shorter diagnostic timelines for the region's seizure patients.